Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients

2 years ago

Groundbreaking Medical Device Company Unveils AI-Powered Software that Improves Diagnostic Imaging Experience for Young PatientsAUSTIN, Texas, July 14, 2022 (GLOBE…

Revelation Biosciences Inc. Completes Database Lock for its Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis

2 years ago

-Topline Data expected in the last week of July-SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ:…

MDbio Start Clinical Trials for Pharmaceutical-Grade Products That Target Sleeplessness, Anxiety and Pain; Expected Retail From 2023

2 years ago

Los Angeles, CA, July 14, 2022 (GLOBE NEWSWIRE) -- MDbio are a leading plant-based, wellness solution who provide safe, pharmaceutical-grade…

Allied Corp Successfully Ships Second Commercial Cannabis Flower Export From Colombia to International Market

2 years ago

KELOWNA, British Columbia, July 14, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to…

Summit Therapeutics Provides Update on Ridinilazole

2 years ago

Menlo Park, CA, July 14, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today…

SCYNEXIS to Present Data from the CANDLE Nested Sub-Study of Ibrexafungerp During the International Society for the Study of Vulvovaginal Disease (ISSVD) XXVI World Congress and International Vulvovaginal Disease Update

2 years ago

JERSEY CITY, N.J., July 14, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to…

WIMI Hologram Academy: Research and Implementation of Electromechanical Operation Simulation System Based on Virtual Reality

2 years ago

HONG KONG, July 14, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $500 Million to OMERS Capital Markets

2 years ago

Strengthens balance sheet with non-dilutive capital at an attractive cost Competitive process results in the sale of 30% of the…

Surgalign Announces Partnership with PRIA Healthcare to Improve Patient Healthcare Coverage

2 years ago

Program to aid in patient access to Surgalign’s Coflex® Interlaminar Stabilization® andSImmetry® SI Joint Fusion Systems DEERFIELD, Ill., July 14, 2022…